Clinical and experimental observations suggest that female sex hormones, and in particular estrogens, increase vascular sensitivity to catecholamines. We confirmed these conclusions by demonstrating in vitro that segments of small mesenteric arteries (190-290 fim in inside diameter) from male rats treated with 17/?-estradiol (10 jug/100 g body weight per day for 5-7 days) exhibited a 3.2-fold leftward shift in the contractile dose-response curve for norepinephrine, the concentration resulting in half maximal contraction decreasing from a control value of 8.4 X 10"' to 2.6 X 10~7 M. The molecular mechanisms which account for this increase in vascular smooth muscle catecholamine sensitivity are unknown. To evaluate directly the possibility that the effects of female sex hormones on the vascular sensitivity to catecholamines are mediated through changes in the a-adrenergic receptor, radioligand-binding studies using the a-1 subtype-selective ligand [ 3 H]-WB-4101 were performed on homogenates of mesenteric arteries in control and estrogen-treated male rats, and in control and oophorectomized female rats. Following estrogen treatment (250 jug/100 g body weight), receptor affinity in male rats was increased 1.9-fold for the antagonist [ 3 H]-WB-4101, and receptor density decreased slightly, from 102 ± 4 to 85 ± 5 fmol/mg protein. Estradiol at doses of 10 and 250 ftg/100 g body weight increased receptor affinity for the agonist (-)-epinephrine 2.8-and 5.7-fold, respectively. The lower dose of estradiol also increased receptor affinity for (-)-norepinephrine 4-fold. In female rats, the affinities for [ 3 H]-WB-4101 and (-)-epinephrine were 1.6-and 3.5fold higher, respectively, than in age-matched males, with no difference in receptor density between the sexes. Following oophorectomy, the affinity for (-)-epinephrine in females was the same as in males. Testosterone treatment did not affect the density or affinity of receptors in females. These observations demonstrate that estrogens increase the affinity of a-adrenergic receptors in blood vessels, and provide evidence that the estrogen-induced increase in vascular sensitivity to catecholamine-induced contraction is mediated, at least in part, by these affinity changes.